Discover proven strategies and insights refined over more than 5,000 launches around the world.


In today's evolving healthcare landscape, asset strategy must do more than differentiate products—it must demonstrate system-wide impact.
This whitepaper introduces IQVIA's Map, Model, Act framework: a next-generation approach to asset and disease area strategy that empowers life sciences companies to align with health system priorities, accelerate adoption, and deliver measurable value to patients and health systems.
Discover how to:
Whether you're developing early commercialization strategy or into launch and market expansion, this framework offers a powerful foundation for building product and disease area strategies that lead in both market performance and healthcare transformation.
Download the whitepaper to learn how your asset can become a catalyst for change.
Re-imagine growth with health system outcomes in mind
Why innovators should take heart from recent advances seen in obesity and beyond
Achieving commercial launch excellence for the most innovative medicines in areas of high unmet need
How to deliver consistent launch performance in an increasingly complex world
How to navigate harsh realities in a highly fluid environment
Deep dive: Antibody drug conjugates, bi-/multi-specifics and radioligand therapies
Integrating multiple IQVIA proprietary data sources to support go-to-market strategy: a case study with an emerging biopharma company
IQVIA launch excellence framework to support an emerging pharma company in launch planning and readiness
Discover proven strategies and insights refined over more than 5,000 launches around the world.